SYNC.L - Syncona Limited

LSE - LSE Delayed price. Currency in GBp
229.50
+4.80 (+2.14%)
As of 1:20PM BST. Market open.
Stock chart is not supported by your current browser
Previous close224.70
Open226.00
Bid228.50 x 0
Ask230.00 x 0
Day's range226.00 - 231.27
52-week range1.93 - 306.50
Volume228,137
Avg. volume328,195
Market cap1.518B
Beta (3Y monthly)N/A
PE ratio (TTM)4.09
EPS (TTM)N/A
Earnings date4 Jul 2018 - 9 Jul 2018
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est320.00
  • PR Newswire10 months ago

    Syncona Limited - Syncona Limited Quarterly Update

    Syncona Limited Quarterly Update 9 August 2018 Syncona Ltd, a leading healthcare company focused on investing in and building global leaders in life science, today issues its quarterly update covering ...

  • PR Newswire11 months ago

    Syncona Limited - PDMR Dealing

    Syncona Limited Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Connected Persons 2 August 2018 1. Details of PDMR / person closely associated with ...

  • PR Newswire11 months ago

    Syncona Limited - Total Voting Rights

    Pursuant to DTR 5.6.1 Syncona Limited (the “Company”) announces that as at 31 July 2018 the total number of ordinary shares in issue now stands at 661,201,473 and the total number of voting rights in the Company is 661,201,473 ordinary shares. The Company does not hold any ordinary shares in treasury.

  • PR Newswire11 months ago

    Syncona Limited - Issue of shares pursuant to the 2018 dividend

    Syncona Limited (the "Company") today announces that a total of 1,249,383 new ordinary shares will be issued in satisfaction of the payment of the Company’s 2018 dividend to those qualifying shareholders who did not elect to receive the dividend in cash.  The new ordinary shares, when issued, will rank pari passu with the existing issued ordinary shares of the Company. Application has been made to the Financial Conduct Authority for the shares to be admitted to the Official List, and to the London Stock Exchange for the shares to be admitted to trading and it is expected that dealings will commence in the new ordinary shares on 30 July 2018.

  • PR Newswirelast year

    Syncona Limited - Monthly Factsheet - May 2018

    Syncona Limited (a closed-ended investment company incorporated in Guernsey with registration number 55514) Monthly Fact Sheet May 2018   Attached is a link to the May 2018 Monthly Fact Sheet for Syncona ...

  • PR Newswirelast year

    Syncona Limited - Publication of 2018 Annual Report and Notice of AGM

    Syncona Limited (“Syncona”), a leading healthcare company focused on investing in and building global leaders in life science, today announces that it has published its Annual Report and Accounts for the year ended 31 March 2018 (“2018 Annual Report”). In addition, Syncona has published its Notice of Annual General Meeting 2018 and a circular relating to the 2018 Dividend.

  • PR Newswirelast year

    Syncona Limited - Autolus update on IPO

    Syncona Ltd, a leading healthcare company focused on investing in and building global leaders in life science, today notes that its portfolio company Autolus Therapeutics plc (“Autolus”) has today announced the pricing of its initial public offering (“IPO”) in the United States of 8,823,530 American Depositary Shares (“ADSs”), at an initial public offering price of $17.00 per ADS for total gross proceeds of approximately $150.0 million (£113.2 million1). All ADSs sold in the IPO were offered by Autolus.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes